Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001209191-21-038917

Director sold 19,415 shares at an average $49.07 ($952,613)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Knowles Julius Director 2021-06-04 Sale −2,988 $47.23 $141,123 552,227 I: show line 1 in the form
Knowles Julius Director 2021-06-04 Sale −1,950 $47.23 $92,099 370,109 I: show line 2 in the form
Knowles Julius Director 2021-06-04 Sale −1,018 $48.15 $49,017 551,209 I: show line 3 in the form
Knowles Julius Director 2021-06-04 Sale −663 $48.15 $31,923 369,446 I: show line 4 in the form
Knowles Julius Director 2021-06-07 Sale −703 $46.48 $32,675 550,506 I: show line 5 in the form
Knowles Julius Director 2021-06-07 Sale −459 $46.48 $21,334 368,987 I: show line 6 in the form
Knowles Julius Director 2021-06-07 Sale −786 $47.34 $37,209 549,720 I: show line 7 in the form
Knowles Julius Director 2021-06-07 Sale −512 $47.34 $24,238 368,475 I: show line 8 in the form
Open-market sales · 19,415 sh · avg $49.07 · $952,613
Loading xslF345X03/doc4.xml…